Stay updated on Nivolumab Post-chemoradiotherapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Post-chemoradiotherapy Clinical Trial page.

Latest updates to the Nivolumab Post-chemoradiotherapy Clinical Trial page
- Check4 days agoChange DetectedAdded study locations for Chiba and Hokkaido and updated the page to revision v3.3.3. Removed the HHS Vulnerability Disclosure link and the previous separate Chiba/Hokkaido location entries.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedThe page adds a note that PubMed publications are automatically filled and may not be about the study. The revision tag was updated to v3.3.2 (from v3.2.0).SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the government funding status notice related to NIH operations. The study page content otherwise remains unchanged and continues to present the trial details, contacts, and locations.SummaryDifference0.4%

- Check54 days agoChange DetectedThe page shows the same study with only minor UI adjustments and small textual edits that do not alter core content or usability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedMajor change: version bump to v3.2.0 and a government-operating-status notice indicating the site may not be up-to-date or fully functional until appropriations are enacted; prior version v3.1.0 was removed.SummaryDifference4%

- Check90 days agoChange DetectedUpdate: version bumped to v3.1.0 with new contact phone numbers added. Deletion of the previous version tag v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Post-chemoradiotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Post-chemoradiotherapy Clinical Trial page.